The global digital health industry, a burgeoning sector anticipated to be valued at an impressive US$ 224.24 billion in 2022, is poised for remarkable growth, projected to ascend at a Compound Annual Growth Rate (CAGR) of 27.7% from 2022 to 2032. Forecasts suggest that by the end of 2032, this industry is estimated to skyrocket …
Category Archives: Healthcare Trends
Global Vital Signs Monitoring Devices Industry to Expand at 8% CAGR, Surpassing US$ 16 Billion by 2033 | FMI
The Global Vital Signs Monitoring Devices Industry is poised for remarkable growth, with a projected valuation of US$ 16 billion by 2033. According to Future Market Insights (FMI), the industry will showcase a robust Compound Annual Growth Rate (CAGR) of 8% from 2023 to 2033, building on an estimated market worth of US$ 7.4 billion …
Global Animal Healthcare Industry on Track for a Remarkable US$ 62.3 Billion Valuation by 2033, Fueled by 4.3% CAGR | Predicted by FMI
The Global Animal Healthcare Industry is poised for an extraordinary surge, with anticipated values reaching US$ 40.9 billion in 2023 and a remarkable US$ 62.3 billion by 2033, according to the latest forecast by Future Market Insights (FMI). This exponential growth is underpinned by a solid compound annual growth rate (CAGR) of 4.3% throughout the …
Global Herbal Medicinal Products Industry Set to Surpass $417.99 Billion by 2033, Driven by Impressive 7.7% CAGR | Reveals FMI Forecast
In a groundbreaking study conducted by Future Market Insights (FMI), the Global Herbal Medicinal Products Industry is set to embark on an extraordinary growth trajectory, with a projected valuation of US$ 199.07 billion by the year 2023. Even more astonishing is the forecast for global herbal medicine sales, expected to surge to an impressive US$ …
Global Biopharmaceutical Contract Manufacturing Industry on Track for 10.5% CAGR, Envisions US$18.7 Billion Market by 2029 | According to FMI
The Global Biopharmaceutical Contract Manufacturing Industry, valued at an estimated US$9.3 billion in 2022, is poised for a remarkable surge with a projected Compound Annual Growth Rate (CAGR) of 10.5%. Forecasts indicate that by 2029, the industry is set to hit a staggering US$18.7 billion. This unprecedented growth underscores the accelerating trend among pharmaceutical companies …
Global Small Molecule (API) Industry Projections Point to US$ 174 Billion Valuation by 2033, Fueled by 4.1% CAGR | FMI
The Global Small Molecule (API) Industry is poised for significant growth, with projections indicating a remarkable surge from US$ 116 billion in 2023 to an estimated US$ 174 billion by 2033. This promising trajectory represents a Compound Annual Growth Rate (CAGR) of 4.1% during the forecast period. The Global Small Molecule (API) Industry, a cornerstone …
Global Radiotherapy Device Industry Sets Sights on US$ 12,895.19 Million by 2033 with Remarkable 6.6% CAGR | Reveals FMI Insights
The Global Radiotherapy Device Industry is on the verge of a transformative era, with a projected market value of US$ 6,805.43 million in 2023, set to double and reach an impressive US$ 12,895.19 million by 2033. This significant expansion is underpinned by a compelling compound annual growth rate (CAGR) of 6.6% during the forecast period …
Global Dry Eye Syndrome Treatment Industry Surpassing US$9.5 Billion by 2033 at a Remarkable 6.4% CAGR | FMI
The Global Dry Eye Syndrome Treatment Industry is gearing up for a transformative journey, marked by a projected Compound Annual Growth Rate (CAGR) of 6.4% over the forecast period. As of 2023, the market has already achieved an impressive valuation of US$ 5,120 million and is poised to reach an estimated US$ 9,521 million by …
North America and Europe Phototherapy Treatment Industry to Reach US$ 3,230.90 Million by 2033, fuelled by a 5.20% CAGR | FMI
The North America and Europe Phototherapy Treatment Industry is poised for remarkable expansion, with projections signaling a valuation of US$ 3,230.90 million by the year 2033. This surge is supported by an impressive Compound Annual Growth Rate (CAGR) of 5.20% during the forecast period, showcasing the industry’s resilience and potential. In 2023, the North America and …
Radiopharmaceuticals Market Aims for US$ 9.5 Billion Milestone by 2032-FMI Projection
The Radiopharmaceuticals Market has experienced substantial growth in recent years, driven by the increasing adoption of nuclear medicine procedures, advancements in molecular imaging technologies, and a growing prevalence of chronic diseases. Radiopharmaceuticals are radioactive compounds used in nuclear medicine imaging and targeted therapy to diagnose and treat various medical conditions, including cancer, cardiovascular diseases, and neurological disorders. …